IP Library Granted Patent US 9,428,547
Granted Patent B2
US 9,428,547 · App. 13/091,506 · Granted Aug 30, 2016

Compositions for isolating a target analyte from a heterogeneous sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,428,547
App. No.
13/091,506
Granted
Aug 30, 2016
Kind
B2
Abstract

The invention generally relates to compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen.

Claims (24)

1. A composition for isolating pathogen from a heterogeneous sample, the composition comprising:

a plurality of sets of magnetic particles, members of different sets being conjugated to different antibodies that are specific for a pathogen, wherein at least two of the sets are at different concentrations; and

a buffer that substantially prevents lysis of blood cells and reduces particle aggregation.

2. The composition of claim 1 , wherein each set is present at a concentration designed for detection of a specific pathogen in said sample.

3. The composition of claim 1 , wherein the particles are differently labeled.

4. The composition of claim 3 , wherein the label is an optical label.

5. The composition of claim 4 , wherein the optical label is a fluorescent label.

6. The composition of claim 1 , wherein the antibodies are monoclonal antibodies.

7. The composition of claim 1 , wherein the antibodies are polyclonal antibodies.

8. The composition of claim 1 , wherein the pathogen are gram positive bacteria.

9. The composition of claim 1 , wherein the pathogen are gram negative bacteria.

10. The composition of claim 1 , wherein the pathogen are gram positive and gram negative bacteria.

11. A plurality of magnetic particles within a buffer that substantially prevents lysis of blood cells and reduces particle aggregation, wherein the plurality is differently functionalized so that the plurality of particles bind to a plurality of different pathogens in a heterogeneous sample, wherein at least some of the differently functionalized particles are at different concentrations.

12. The particles of claim 11 , wherein the particles are differently labeled.

13. The particles of claim 12 , wherein the label is an optical label.

14. The particles of claim 13 , wherein the optical label is a fluorescent label.

15. The particles of claim 11 , wherein the antibodies are monoclonal antibodies.

16. The particles of claim 11 , wherein the antibodies are polyclonal antibodies.

17. The particles of claim 11 , wherein the pathogen are gram positive bacteria.

18. The particles of claim 11 , wherein the pathogen are gram negative bacteria.

19. The particles of claim 11 , wherein the pathogen are gram positive and gram negative bacteria.

20. A composition for isolating bacteria from a heterogeneous sample, the composition comprising:

a plurality of sets of magnetic particles, members of different sets being conjugated to different antibodies that are specific for a bacteria, wherein at least two of the sets are at different concentrations; and

a buffer that substantially prevents lysis of blood cells and reduces particle aggregation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 041154/0786 →
MERGER Recorded Jan 22, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 037558/0982 →
CHANGE OF NAME Recorded Dec 29, 2015
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 037372/0862 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2011
From: DRYGA, SERGEY A.; ESCH, VICTOR C.; CLARIZIA, LISA-JO ANN; ADAMS, EDDIE W.; UNG, THEARITH H.; SITDIKOV, RAVIL A.
To: NANOMR, INC.
Reel/Frame 026505/0462 →